We are a boutique consulting firm offering services to life sciences companies. We are focused on strategy. Our team prides itself on the high calibre, expertise and vast breadth of experience that it has accumulated over the last 2 decades.
We have been providing consulting support to pharmaceutical, biotechnology and medical device companies since 2004. The projects that we have delivered on in the past include everything from desk research on new disease areas to global commercial assessments for new products. We have developed hundreds of forecast models and decision support tools in Excel. We have set up health economic models to support pricing. Our team develops discussion guides, runs telephone interviews with HCPs, conducts payer interviews and moderates focus groups. Our tech group programmes online surveys, recruits respondents globally and helps develop slides. We can provide consulting support for any company that is looking to commercialise a new product, change existing strategy, decide on a pricing strategy or value an asset for in-licensing / out-licensing / partnering. We can also run desk research or market research for you globally.
We can guarantee you high quality work.
Click here to download our capabilities presentation
Competencies
We help you understand the potential of specific therapeutic areas, country markets, soon-to-be launched products and early stage molecules, including intellectual property. Our offerings are designed to maximize returns from your R&D, business development, licensing and marketing efforts.
We conduct primary market research, secondary research and data analysis to help develop strategy at the product and business level. We set up custom models for quantitative assessment of strategies, scenario analyses and development of strategic options. The information and analysis that we deliver along with our decision tools facilitate structured thinking and decision making.
We also run custom workshops and participate in on-site meetings as needed to provide support to clients during projects.
We are unique in having the processes and resources in place to provide rapid turnarounds with global projects.
Services
Our services are designed to help with Market Access, Business Development & Licensing, Business Analysis, Strategic Planning, Strategic Marketing and Pricing & Reimbursement.
We have the skills and resources to conduct market, product and service evaluations globally – USA, EU, Japan, China – including emerging markets. We have extensive experience in conducting global opportunity assessments for medicines at all stages in their life cycle.
We have been in this space for 18 years now and have conducted projects to support decisions around (a) funding for early stage companies, (b) advancing an asset across phases of clinical trials, (c) drug licensing opportunities, (d) valuation of revenue streams for monetization (e) pricing new products, (f) market scoping and (g) developing a viable target product profile. We have developed forecasts for hundreds of new products, including valuations for many. We also develop health economic models including evidence synthesis to support pricing and reimbursement.
We have processes in place to provide results very rapidly to our clients with many projects taking only under 4 weeks from commissioning to delivery.
If you are a smaller consulting firm or a freelance consultant and require support with a consulting project, we can work with you at any stage of the project or for completing any module within the project. This may include help with secondary research, primary research globally, Excel model development for forecasting, Markov or decision tree model development for cost effectiveness analysis or just about any work associated with the project. Please feel free to contact us with your requirement.
Focus areas
Market opportunity assessment
TPP evaluation
Market sizing
Forecasting
Primary market research
Secondary research
Online surveys
Conjoint & choice studies
Payer research
Systematic review for assumptions
Microsimulation models
Markov models
Disease area strategy
Portfolio strategy
Product strategy
Planning workshops
Valuation of assets
In licensing / out licensing
Royalty stream valuation
